Kary Eldred is of GALECTIN THERAPEUTICS INC. Currently has a direct ownership of 50,213 shares of GALT, which is worth approximately $135,575. The most recent transaction as insider was on Oct 23, 2024, when has been sold 500 shares (Common Stock) at a price of $2.6 per share, resulting in proceeds of $1,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.2K
1.01% 3M change
2.87% 12M change
Total Value Held $135,575

KARY ELDRED Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 23 2024
BUY
Open market or private purchase
$1,300 $2.6 p/Share
500 Added 0.99%
50,213 Common Stock
Jan 16 2024
BUY
Open market or private purchase
$956 $2.39 p/Share
400 Added 0.8%
49,713 Common Stock
Jan 16 2024
BUY
Open market or private purchase
$895 $1.79 p/Share
500 Added 1.0%
49,313 Common Stock
Jul 19 2023
BUY
Open market or private purchase
$2,860 $1.79 p/Share
1,598 Added 3.17%
48,813 Common Stock
Feb 21 2023
BUY
Open market or private purchase
$1,590 $1.59 p/Share
1,000 Added 2.07%
47,215 Common Stock
Jan 25 2023
BUY
Open market or private purchase
$1,443 $1.11 p/Share
1,300 Added 2.74%
46,215 Common Stock
KE

Kary Eldred

Norcross, GA

Track Institutional and Insider Activities on GALT

Follow GALECTIN THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GALT shares.

Notify only if

Insider Trading

Get notified when an Galectin Therapeutics Inc insider buys or sells GALT shares.

Notify only if

News

Receive news related to GALECTIN THERAPEUTICS INC

Track Activities on GALT